In a post on X.com, Neuralink said it had been granted regulatory approval for "a new feasibility trial to extend BCI control ...

The FDA is scrutinising reports of haematological cancers in patients treated with bluebird bio's gene therapy for the rare ...

Healthcare professionals (HCPs) expect digital experiences to be as seamless and personalised as the apps and services they ...

The sell-off started last night and continued in after-hours trading after the New York-based biopharma company revealed that ...

The IL-5 inhibitor is already available under the Fasenra brand name for maintenance use in severe eosinophilic asthma, but a ...

Great Place to Work, Built Ins: Top Biotech Companies 2024, Forbes Best Places to Work in Life Sciences are joining our LEAP ...

“It’s a really exciting time, not just for NWEH, but also for the future of clinical trials in the UK. If successful, this ...

The company made its debut last year with a $51 million Series A and a licensing agreement with Astellas for a gene therapy ...

In the era of digital health transformation, generative AI (GenAI) has emerged as a breakthrough technology in ...

Significant breakthroughs in CNS biology, coupled with innovative neuroscience technologies and a more supportive regulatory ...

The European Commission has cleared use of CDK4/6 inhibitor Kisqali (ribociclib) to reduce the risk of recurrence in patients ...

That increased convenience will have to be accompanied by weight loss that is at least as effective as its rivals, and Amgen ...